CNTA Financials

Centessa Pharmaceuticals PLC ADR - Financial statements & key metrics

Stock Price

$0.00

Market Cap

$6.15B

EPS

$-1.89

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-235.76M

EPS (Diluted)

$-2.06

Balance Sheet Highlights

Total Assets

$576.80M

Total Liabilities

$175.25M

Shareholders Equity

Cash & Equivalents

$383.22M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-142.06M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

-1425.3%

ROE

-60.6%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CNTA revenue?

View CNTA's income statement for detailed revenue data.

Is CNTA profitable?

CNTA reported a loss of $235.76M in the most recent quarter.

What is CNTA market cap?

CNTA has a market capitalization of $6.15B, making it a mid-cap stock.

Does CNTA have debt?

View CNTA's balance sheet for debt information.

What is CNTA cash flow?

Cash flow data is available in the full financial statements.